Christopher Posner

Christopher Posner

Former (Cara) President and Chief Executive OfficeratTvardi Therapeutics· In proxies 2024–2025

Pay in FY2025+141% from the year before · Tvardi Therapeutics stock -76.6% the same year

Christopher Posner was paid $2.6M in FY2025 (Dec), up 141%. Tvardi Therapeutics stock fell 76.6% that year.

Pay$100 in the stock at the end of FY23 → $16
Pay is from the Summary Compensation Table of each Tvardi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tvardi TherapeuticsPublic company · 2 yr
    • Former (Cara) President and Chief Executive Officer2024 – Present · 2 yrStock in role -96%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?